Our Corporate Relations
Keiretsu Forum Nordic (KFN)
KFN is the Nordic go-to place for investors, entrepreneurs, and supporters to get high-quality deal flow and resources in the form of capital, network, training, and services to enhance innovation and success for the entire investor and venture community.
Visit keiretsuforumnordics.com
Beijing Zhongfa Wealth Investment Fund Management Co., Ltd (Zhongfa)
Zhongfa focuses on strategic and innovative private equity investment. Zhongfa manages the domestic first-class large-scale health industry fund.
China Union of Life Science Association
This association gathers 22 professional societies which focus on the world’s leading areas of biomedicine and industry development and innovation in Life Sciences – Genomics New Technology, Stem cell technology, Bio big data, etc. to build a package Biopharmaceuticals, bioenergy, biomanufacturing and more
Technology product development, production, circulation and service as one
industrial cluster.
Life Science Industry Cluster
Relying on life science innovation technology-new genomics technology, stem cell technology, biological big data, etc., to create an industrial cluster including biomedicine, bioenergy, biomanufacturing and other biotechnology product research and development, production, distribution and services Build a highland of life science industry.
Cutting-edge medical service cluster
With general hospitals as the core, comprehensive specialty hospitals and specialty outpatient clinics form cutting-edge medical complexes, and build medical and R & D application bases, introduce innovative technologies such as the Internet, create shared platforms, informatization and smart medical service platforms, and finally form new medical services Demonstration area of industry.
Health and Leisure Industry Cluster
With general hospitals as the core, comprehensive specialty hospitals and specialty outpatient clinics form cutting-edge medical complexes, and build medical and R & D application bases, introduce innovative technologies such as the Internet, create shared platforms, informatization and smart medical service platforms, and finally form new medical services Demonstration area of industry.
Fudan College of Life Sciences, Fudan University
Fudan University has the most complete ecosystem for the development of precision medicine and has a complete industrialization chain from scientific research and development to clinical medicine. Fudan College of Life Sciences is a fine forefront of basic research related to quasi-medicine, 11 hospitals affiliated to Fudan are the clinical trials and application positions of innovative medical technology for precision medicine.
Fudan College of Life Science
Focus on the core areas of precision medicine for industrial operations:
Accurate diagnosis: Molecular diagnosis / molecular imaging and artificial intelligence detection technology, etc.
Precision treatment: Immunotherapy / Cell therapy / Targeted drugs, etc.
Precise prevention: Reduce the incidence and reduce the burden of medical insurance through early warning, disease prevention and control.
Precision rehabilitation: according to the characteristics of individual differences, postoperative rehabilitation treatment of major diseases is performed to improve the quality of life of patients.
Capital Financial Holding Group Co.,Ltd. (CFHC)
Controlling shareholder: China Health Industry Investment Fund Management Co., Ltd.,
China Health Industry Investment Fund Co., Ltd.( CHIC)
State-level industrial fund management company.
China Academy of Chinese Medical Sciences
Taking medical, rehabilitation and health management construction as the basis, it integrates a modern and leading concept of the aging people service integration system into the aging people care industry. Relying on the National Cardiovascular Disease Center and 301 Multidisciplinary Consultation Center, a geriatric hospital was established to serve the medical and nursing population.
Sino Pharm Group
In 2019, Sino Pharm Group’s operating income was nearly 500 billion yuan, ranking 169th in the list of the world’s top 500 companies, and ranking sixth in the world’s top 500 list of pharmaceutical companies. In the ranking of the top 25 global brand value pharmaceutical companies released by the international authoritative brand value consulting company Brand Finance, Sino Pharm Group ranked first in Asia.